Gilead claims US government PrEP patents are invalid

20-05-2019

Gilead claims US government PrEP patents are invalid

eyesonmilan / Shutterstock.com

Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control (CDC) HIV prevention patents are invalid.


Gilead, HIV, PrEP, Centre for Disease Control, CDC, House committee, Truvada, Daniel O’Day

LSIPR